Perspectives

All Items

• Aducanumab: The Controversial New Drug Licensed to Treat Alzheimer’s Disease

  Ava Janes

  6-11

• Ignoring Emerging Infectious Diseases: The Fatal Error That Could Lead to the Next Pandemic

  Karlo Vidovic

  12-16